Homogeneous immune quantitative detection method of ricin

By optimizing the combination of lanthanide fluorescent microspheres and allophycocyanin fluorescent dyes, a high-sensitivity homogeneous immunoassay method was established, which solved the problem of insufficient fluorescence intensity of lanthanide hole-like compounds and achieved rapid and specific castors The test for anesthetic toxins is 38ng/mL.

CN119044469APending Publication Date: 2024-11-29ACADEMY OF MILITARY MEDICAL SCIENCES

Patent Information

Application Number
CN202411203787.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The fluorescence intensity of the lanthanide hole-like compounds used for ricin detection in the prior art is not high, making it difficult to achieve high sensitivity homogeneous time-resolved fluorescence detection.

Method used

Using lanthanide fluorescent microspheres and allophytocyanin fluorescent dyes as fluorescent donors and acceptors, a homogeneous immunoassay method was established by optimizing the particle size of the microspheres, the coating amount of lanthanide elements and the reaction conditions, and using time resolution Fluorescence technology performs quantitative detection of ricin.

Benefits of technology

It realizes fast, specific and sensitive ricin detection, with the lower limit of detection reaching 38ng/mL, which is easy to operate and does not require cleaning, and is suitable for on-site inspection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119044469A_ABST
    Figure CN119044469A_ABST
Patent Text Reader

Abstract

The invention provides a homogeneous immune quantitative detection method of ricin, and belongs to the technical field of homogeneous immune detection. Mixing the activated lanthanide fluorescent microsphere suspension and the anti-ricin polyclonal antibody, and sealing by using a BSA (Bovine Serum Albumin) solution to obtain a coupling solution A; reacting the activated allophycocyanin with an anti-ricin monoclonal antibody, and sealing by using a DMSO solution to obtain a coupling solution B; mixing and reacting ricin standard solutions with different concentrations with the coupling solution A and the coupling solution B respectively, measuring the time-resolved fluorescence of the system at 665nm, and establishing a standard curve by taking the ricin concentration as an abscissa and taking the fluorescence intensity corresponding to the concentration at 665nm as an ordinate; measuring the fluorescence intensity at 665nm after the coupling solution A, the coupling solution B and the ricin solution are mixed and reacted, and obtaining the content of ricin in the ricin solution according to the standard curve. The method for rapidly, specifically and sensitively detecting the ricin is established, and the lower detection limit reaches 38ng / mL.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of homogeneous immunoassay, and in particular relates to a homogeneous immunoassay quantitative detection method for ricin. Background Art

[0002] Ricin (RT) is a highly toxic glycoprotein biotoxin extracted from castor seeds. The molecular weight of ricin is about 65KDa, and it is a glycoprotein heterodimer composed of two polypeptide chains A and B connected by disulfide bonds. Ricin is composed of chain A (RTA) and chain B (RTB). RTA is the toxic chain with glycosidase activity; RTB has lectin activity. It binds to galactose-containing glycoproteins or glycolipids on cells with two galactose binding sites on its polypeptide chain, releasing RTA to exert toxic effects. It is a potential bioterrorist agent, and no effective antidote has been developed yet. Therefore, it is crucial to quickly identify and diagnose ricin poisoning on site. The main detection methods currently include immunolabeling analysis, biomass spectrometry, and biosensor methods. Conventional methods have some defects that are not conducive to on-site detection. ELISA, as a commonly used immunoassay method, takes a long time to detect; mass spectrometry has high sensitivity, but the mass spectrometer is expensive and requires a high level of professionalism from the operator, so it is not suitable for on-site detection.

[0003] Time-resolved fluoroimmunoassay (TRFIA) is a non-isotopic fluorescent immunoassay that uses the larger Stokes shift of rare earth ions to avoid the influence of the self-luminescence of solutions and materials. It can effectively eliminate the interference of nonspecific fluorescence and improve sensitivity. Fluorescence Resonance Energy Transfer (FRET) is an emerging molecular spectroscopy analysis method and a non-radiative energy transfer process. It was first proposed by Forster in 1948, so it is also called Forster energy transfer. It uses the energy transfer between the two fluorescent groups, the fluorescent donor and the fluorescent acceptor. Only when the two are close enough can energy transfer occur and emit light of a specific wavelength.

[0004] Homogeneous time-resolved fluorescence (HTRF) technology is a common method for detecting analytes in homogeneous systems, combining fluorescence resonance energy transfer (FRET) and time-resolved fluorescence (TRF) technologies. In the prior art, lanthanide cryptates are usually used in combination with homogeneous time-resolved fluorescence technology to detect ricin, but the fluorescence intensity of lanthanide cryptates is not high and is not conducive to the collection of fluorescence signals. Therefore, it is urgent to provide a new homogeneous time-resolved fluorescence detection method to achieve quantitative detection of ricin. Summary of the invention

[0005] In view of this, the object of the present invention is to provide a homogeneous immunoquantitative detection method for ricin, which is simple to operate, requires a small amount of sample, does not require cleaning, has high specificity, and is extremely suitable for on-site detection.

[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0007] The present invention provides a homogeneous immunoquantitative detection method for ricin, comprising the following steps:

[0008] 1) mixing a lanthanide fluorescent microsphere suspension, NHS and EDC to obtain an activated lanthanide fluorescent microsphere suspension; mixing the activated lanthanide fluorescent microsphere suspension and an anti-ricin polyclonal antibody, and then adding a BSA solution to block the mixture to obtain a coupling solution A;

[0009] 2) After the activated allophycocyanin and anti-ricin monoclonal antibody are reacted, DMSO solution is added for blocking to obtain coupling solution B;

[0010] 3) at least three different concentrations of ricin standard solutions are mixed with coupling solution A and coupling solution B respectively to react, and after the reaction is completed, the time-resolved fluorescence of the system at 665 nm is measured, and a standard curve is established with the concentration of ricin as the abscissa and the fluorescence intensity at 665 nm corresponding to the concentration as the ordinate;

[0011] After the coupling liquid A, coupling liquid B and ricin solution are mixed and reacted, the time-resolved fluorescence of the system at 665 nm is measured, and the content of ricin in the ricin solution is calculated based on the fluorescence intensity of the ricin solution and the standard curve.

[0012] Preferably, in step 1), the particle size of the lanthanide fluorescent microspheres in the lanthanide fluorescent microsphere suspension is 80-120 nm; the coating amount of the lanthanide element in the lanthanide fluorescent microspheres is 0.2×10 -6 ~2×10 -6 mol / mL.

[0013] Preferably, in step 3), the concentration of the coupling liquid A is 0.5-1 μg / mL; the concentration of the coupling liquid B is 10-20 μg / mL.

[0014] Preferably, in step 3), the volume ratio of the coupling liquid A, coupling liquid B and ricin solution is 1:1-3:3-5.

[0015] Preferably, the reaction time in step 3) is 5 to 15 minutes.

[0016] Preferably, in step 1), the concentration of the lanthanide fluorescent microsphere suspension is 5-15%; the concentration of the NHS is 5-15 mg / mL; the concentration of the EDC is 5-15 mg / mL; and the volume ratio of the lanthanide fluorescent microsphere suspension, NHS and EDC is 180-220:1:1.

[0017] Preferably, the final concentration of the BSA solution in step 1) is 0.3-0.8%; the mass ratio of the activated lanthanide fluorescent microsphere suspension, the anti-ricin polyclonal antibody and the BSA solution is 1:80-120:40-60.

[0018] Preferably, in step 2), the mass ratio of the activated allophycocyanin to the anti-ricin monoclonal antibody is 1 to 3:1.

[0019] Preferably, the concentration of the DMSO solution in step 2) is 5-15 mg / mL; the mass volume ratio of the anti-ricin monoclonal antibody to the DMSO solution is 0.3-0.8 mg:3-8 μL.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] The present invention uses lanthanide fluorescent microspheres as fluorescence donors and allophycocyanin fluorescent dye as fluorescence acceptor. By optimizing the particle size of the lanthanide fluorescent microspheres, the coating amount of the lanthanide elements in the fluorescent microspheres, the solution concentration and the reaction time, a homogeneous immunoassay method for rapid, specific and sensitive detection of ricin toxin is established, and the detection limit can reach 38 ng / mL.

[0022] The homogeneous immunoassay method adopted in the present invention is to place the detection reagent and the object to be detected in the same medium for detection. The reaction and detection process are in the same medium, and the whole process does not require cleaning. The operation is simple and the reaction is uniform. You only need to put the sample to be tested and the reagents required for the detection together and wait for the reaction time to end, and then you can directly read the numerical judgment result. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 are the emission spectrum of lanthanide fluorescent microspheres and the emission spectrum of allophycocyanin in the present invention (wherein (a) is the emission spectrum of lanthanide fluorescent microspheres, and (b) is the emission spectrum of allophycocyanin);

[0024] Figure 2 is the standard curve of ricin concentration and fluorescence intensity at 665 nm;

[0025] Figure 3is a comparison of the fluorescence intensity of lanthanide fluorescent microspheres and lanthanide cryptates at an emission wavelength of 615 nm (wherein (a) is the fluorescence intensity of lanthanide fluorescent microspheres at an emission wavelength of 615 nm, and (b) is the fluorescence intensity of lanthanide cryptates at an emission wavelength of 615 nm);

[0026] Figure 4 It is the specificity of the detection method in the present invention;

[0027] Figure 5 It is the change of fluorescence intensity after the microspheres with the same particle size are coated with different lanthanide element concentrations;

[0028] Figure 6 The effect of microspheres with different particle sizes coated with the same antibody on the test results;

[0029] Figure 7 is the effect of different reaction times on the test results (where (a) is the test immediately after adding the system, (b) is the test after 5 minutes, (c) is the test after 10 minutes, and (d) is the test after 15 minutes);

[0030] Figure 8 is the effect of different solution concentrations and dosages on the test results (wherein, (a) is the effect of different total test volumes on the test results, (b) is the effect of different APC-coupled antibody concentrations on the test results, and (c) is the effect of different lanthanide microsphere-coupled antibody concentrations on the test results);

[0031] Fig. 9 It is the minimum detection limit of the present invention. DETAILED DESCRIPTION

[0032] The present invention provides a homogeneous immunoquantitative detection method for ricin, comprising the following steps:

[0033] 1) mixing a lanthanide fluorescent microsphere suspension, NHS and EDC to obtain an activated lanthanide fluorescent microsphere suspension; mixing the activated lanthanide fluorescent microsphere suspension and an anti-ricin polyclonal antibody, and then adding a BSA solution to block the mixture to obtain a coupling solution A;

[0034] 2) After the activated allophycocyanin and anti-ricin monoclonal antibody are reacted, DMSO solution is added for blocking to obtain coupling solution B;

[0035] 3) at least three different concentrations of ricin standard solutions are mixed with coupling solution A and coupling solution B respectively to react, and after the reaction is completed, the time-resolved fluorescence of the system at 665 nm is measured, and a standard curve is established with the concentration of ricin as the abscissa and the fluorescence intensity at 665 nm corresponding to the concentration as the ordinate;

[0036] After the coupling liquid A, coupling liquid B and ricin solution are mixed and reacted, the time-resolved fluorescence of the system at 665 nm is measured, and the content of ricin in the ricin solution is calculated based on the fluorescence intensity of the ricin solution and the standard curve.

[0037] In the present invention, a lanthanide fluorescent microsphere suspension, NHS and EDC are mixed to react to obtain an activated lanthanide fluorescent microsphere suspension; the particle size of the lanthanide fluorescent microspheres in the lanthanide fluorescent microsphere suspension is preferably 80 to 120 nm, more preferably 85 to 115 nm; the coating amount of the lanthanide element in the lanthanide fluorescent microsphere is preferably 0.2×10 -6 ~2×10 -6 mol / mL, more preferably 0.5×10 -6 ~1.8×10 -6 mol / mL; the concentration of the lanthanide fluorescent microsphere suspension is preferably 5-15%, more preferably 7-12%; the concentration of NHS is preferably 5-15 mg / mL, more preferably 7-12 mg / mL; the concentration of EDC is preferably 5-15 mg / mL, more preferably 7-12 mg / mL; the volume ratio of the lanthanide fluorescent microsphere suspension, NHS and EDC is preferably 180-220:1:1, more preferably 190-210:1:1; the reaction time is 15-30 min; centrifugation after the reaction, the speed of the centrifugation is preferably 13000-15000 r / min, more preferably 13000-15000 r / min; the precipitate after centrifugation is ultrasonically dispersed with ultrapure water to obtain an activated lanthanide fluorescent microsphere suspension. The activated lanthanide fluorescent microsphere suspension and the anti-ricin polyclonal antibody are mixed and then blocked with a BSA solution to obtain a coupling solution A. The final concentration of the BSA solution is preferably 0.3-0.8%; the mass ratio of the activated lanthanide fluorescent microsphere suspension, the anti-ricin polyclonal antibody and the BSA solution is preferably 1:80-120:40-60, and more preferably 1:90-110:45-55.

[0038] In the present invention, after the activated allophycocyanin and the anti-ricin monoclonal antibody are reacted, a DMSO solution is added for sealing to obtain a coupling solution B. The mass ratio of the activated allophycocyanin and the anti-ricin monoclonal antibody is preferably 1-3:1, and more preferably 1.5-2.5:1; the reaction time is preferably 1-3h, and more preferably 1.5-2.5h; the concentration of the DMSO solution is preferably 5-15mg / mL, and more preferably 7-12mg / mL; the mass volume ratio of the anti-ricin monoclonal antibody and the DMSO solution is preferably 0.3-0.8mg:3-8μL, and more preferably 0.4-0.7mg:4-7μL.

[0039] In the present invention, at least three ricin standard solutions with different concentrations are mixed with coupling solution A and coupling solution B respectively to react, and after the reaction is completed, the time-resolved fluorescence of the system at 665 nm is measured, and a standard curve is established with the concentration of ricin as the abscissa and the fluorescence intensity at 665 nm corresponding to the concentration as the ordinate;

[0040] After the coupling liquid A, coupling liquid B and ricin solution are mixed and reacted, the time-resolved fluorescence of the system at 665 nm is measured, and the content of ricin in the ricin solution is calculated according to the fluorescence intensity of the ricin solution and the standard curve. The concentration of the coupling liquid A is preferably 0.5-1 μg / mL, and more preferably 0.6-0.9 μg / mL; the concentration of the coupling liquid B is preferably 10-20 μg / mL, and more preferably 12-18 μg / mL; the volume ratio of the coupling liquid A, coupling liquid B and ricin solution is preferably 1:1-3:3-5, and more preferably 1:1.5-2.5:3.5-4.5; the reaction time is preferably 5-15 min, and more preferably 7-12 min.

[0041] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0042] Anti-ricin monoclonal antibody and anti-ricin polyclonal antibody were prepared by our laboratory. The ricin antibody preparation process: 20mM PB, 300mM NaCl, pH adjusted to 7.8 as A solution; 0.1M citric acid, pH adjusted to 4.0 as B solution; 1M Tris-HCL, pH adjusted to 8.0 as neutralizing solution. Dilute 5mL rabbit serum with 15mL A solution, filter with 0.45μm filter and set aside. Then use A solution to balance the affinity column for 5 column volumes, flow through at a flow rate of 5mL / min, load at a flow rate of 2mL / min, elute impurities with A solution, and elute with 100% B solution.

[0043] The allophycocyanin kit was purchased from Frdbio with the catalog number ARL0023K-1.

[0044] Example 1

[0045] 1. Preparation of lanthanide fluorescent microspheres

[0046] EuCl3·6H2O (obtained by rotary evaporation after reaction of Eu2O3 with HCl), 1-naphthalene-3-thiophene-1,3-propanedione and TOPO were added to acetone in a molar ratio of 1:3:3, and the mixture was stirred at room temperature for 3 hours to prepare a europium complex; a seeded emulsion polymerization method was used to prepare monodisperse colloidal microspheres with an average diameter of nanometers as "seed" particles; based on the seed particles, a corresponding volume of styrene was added according to the required particle size, and the europium complex and a swelling agent (mass ratio of 1:0.2 to 1:200-1:600) were added while rotating to allow the europium complex to penetrate into the interior of the microspheres, and then the swelling agent was removed by rotary evaporation.

[0047] Lanthanide fluorescent microspheres with a solid content of 2% and a particle size of 100 nm were used. After diluting them 100 times, a full-wavelength scanning enzyme-linked analyzer was used to fix the excitation wavelength at 385 nm, and the emission wavelength was recorded starting from 450 nm, with a reading taken every 10 nm.

[0048] Experimental results: Figure 1 As shown in (a), the optimal emission wavelength of lanthanide microspheres is around 615 nm.

[0049] 2. Lanthanide fluorescent microspheres labeled antibodies

[0050] First, the lanthanide fluorescent microspheres are activated, 100 μL of lanthanide fluorescent microspheres with a particle size of 100 nm are added, and then 900 μL of ultrapure water is added for standby use; 5 μL of 10 mg / mL NHS and EDC are added to the microsphere suspension, and the mixture is fully mixed and reacted at room temperature for 15 to 30 minutes; then, the mixture is centrifuged at a speed of 14000 r / min for 15 minutes, and 1 mL of ultrapure water is added for ultrasonic dispersion; the anti-ricin polyclonal antibody is added to the activated microsphere suspension, and after mixing at room temperature for 1 hour, BSA (final concentration of 0.5%) is added for blocking for 1 hour; the mass ratio of the anti-ricin polyclonal antibody, lanthanide fluorescent microspheres and BSA is 1:100:50. Then, the mixture is centrifuged at a speed of 13000 r / min for 15 minutes, and a preservation solution is added for standby use.

[0051] 3. Allophycocyanin fluorescent dye labeled antibodies

[0052] 1. Modification of anti-ricin monoclonal antibodies

[0053] (1) Take anti-ricin monoclonal antibody (purity> 90%), adjust the concentration to about 5 mg / mL, add 2 μL of antibody modification reagent solution per mg of anti-ricin monoclonal antibody, mix gently, and react at room temperature in the dark for 90 minutes;

[0054] (2) After the reaction is completed, it is transferred to a 30KMWCO ultrafiltration tube and ultrafiltered with a labeled buffer for 3-5 times (each time at 12000 rpm for 5 min). The volume of the liquid in the tube core each time should not exceed 1 / 4 of the original volume. After the last ultrafiltration, the liquid in the tube core is the modified anti-ricin monoclonal antibody.

[0055] 2. Activated APC protein coupled with anti-ricin monoclonal antibody

[0056] (1) Redissolve the activated APC protein with labeling buffer and adjust the concentration to 5 mg / mL (0.75 mg of activated APC protein is added to 150 μL of labeling buffer for redissolution);

[0057] (2) mixing the modified anti-ricin monoclonal antibody and the activated APC protein at a mass ratio of 1:2 (2 mg of activated APC protein for every mg of modified antibody) and reacting at room temperature in the dark for 2 hours;

[0058] (3) Add 5 μL of DMSO to the blocking reagent tube to prepare a 10 mg / mL blocking reagent solution; add 5 μL of DMSO per 0.5 mg of antibody to the reaction product of step 2) to block the unreacted active gene;

[0059] (4) Aliquot the labeled antibodies, add appropriate protective agents, and store at -20°C until needed.

[0060] The emission wavelength of allophycocyanin was spectrally scanned using an enzyme reader.

[0061] Experimental results: Figure 1 As shown in (b), APC is excited by the light emitted by lanthanide fluorescent microspheres at 615 nm, and APC has the strongest emission light at around 665 nm.

[0062] IV. Immune Response

[0063] Lanthanide fluorescent microspheres and antibodies labeled with allophycocyanin fluorescent dye are sequentially added to the reaction pool. The coupling solution A of lanthanide fluorescent microspheres and anti-ricin polyclonal antibodies can have a solution concentration of 0.8ug / mL; the coupling solution B of allophycocyanin fluorescent dye and anti-ricin monoclonal antibodies can have a solution concentration of 16ug / mL. Use 5μL and 10μL of each, and then add 20μL of the diluted ricin solution for testing.

[0064] 5. Signal Detection

[0065] Using PBS as solvent, prepare ricin standard solutions with concentrations of 0ng, 1ng, 5ng, 10ng, 50ng and 100ng, respectively. Take 20μL of ricin standard solutions of different concentrations, mix with 5μL of anti-ricin polyclonal antibody labeled with lanthanide fluorescent microspheres and 10μL of anti-ricin monoclonal antibody labeled with allophycocyanin fluorescent dye, and react at room temperature for 5 minutes. After incubation, use a high-sensitivity fluorescence analyzer to detect the time-resolved fluorescence of the system at 665nm. Set the concentration of ricin as the horizontal axis, and the fluorescence value at 665nm corresponding to the concentration as the vertical axis, so as to establish a standard curve, such as Figure 2 shown.

[0066] Table 1 shows the fluorescence intensity at 665 nm corresponding to the standard solutions of ricin at different concentrations.

[0067] Concentration (ng) Fluorescence intensity at 665 nm 0 34657821 1 34795260 5 34919152 10 35742306 50 38989417 100 42810716

[0068] After the test system is mixed and reacted for 5 minutes, the time-resolved fluorescence at 665nm is collected using a high-sensitivity fluorescence analyzer. The content of ricin in the ricin test sample can be determined based on the fluorescence value of the ricin test sample at 665nm and the obtained standard curve.

[0069] Example 2

[0070] The same volume of lanthanide cryptate and lanthanide fluorescent microspheres were selected and diluted in the same proportion, and irradiated with 385 nm excitation light to detect the corresponding fluorescence intensity.

[0071] Experimental results: Figure 3 As shown, since the lanthanide microspheres can encapsulate more lanthanide fluorescent dyes, the fluorescence intensity of the lanthanide fluorescent microspheres measured at 665nm is higher than that of the lanthanide cryptate compounds, which can not only expand the sensitivity detection range, but also reduce costs and shorten the detection time.

[0072] Example 3

[0073] Specificity experiments

[0074] 5 μL of anti-ricin polyclonal antibody labeled with lanthanide fluorescent microspheres and 10 μL of anti-ricin monoclonal antibody labeled with allophycocyanin fluorescent dye were selected, and 20 μL of ricin and abrin of different concentrations were mixed and reacted at room temperature for 5 minutes.

[0075] Experimental results: Figure 4 As shown, after the reaction, the fluorescence intensity of ricin increases with the increase of toxin concentration, but this phenomenon does not occur with abrin toxin, and the fluorescence intensity of abrin toxin is much smaller than that of ricin, the energy transfer efficiency is extremely low, and no specific reaction occurs.

[0076] Example 4

[0077] Changes in fluorescence intensity after microspheres of the same size were coated with different lanthanide concentrations

[0078] Select 100nm particle size microspheres and coat them with lanthanide elements 1.2*10e 17 / mL、0.12*10e 17 / mL, 2.4*10e 17 / mL to carry out the experiment, add 100ng / mL and 1ng / mL of toxin concentrations into the reaction system respectively, and detect the fluorescence value.

[0079] Experimental results: Figure 5 As shown, the detection system uses 100nm coated lanthanide element 1.2*10e 17 / mL detects toxins of different concentrations, the fluorescence intensity changes significantly. Below this coating amount, the fluorescence intensity does not change significantly. Above this coating amount, the excessively high fluorescence intensity of the lanthanide elements masks the actual fluorescence value at 665nm, resulting in inaccurate test results.

[0080] Example 5

[0081] Effects of different particle size microspheres with the same antibody coating amount on the test results

[0082] Microspheres with particle sizes of 85nm, 100nm and 300nm were coated with 0.1mg / mL antibody for the experiment. Toxin concentrations of 100ng / mL and 1ng / mL were added to the reaction system for fluorescence detection.

[0083] Experimental results: Figure 6 As shown, the fluorescence intensity of 100nm microspheres changed significantly when detecting toxins of different concentrations, while the fluorescence intensity of 85nm and 300nm microspheres did not change significantly under the same experimental conditions.

[0084] Example 6

[0085] Effects of different reaction times on test results

[0086] 5 μL of anti-ricin polyclonal antibody labeled with lanthanide fluorescent microspheres and 10 μL of anti-ricin monoclonal antibody labeled with allophycocyanin fluorescent dye were selected, and 20 μL of ricin of different concentrations were mixed and reacted at room temperature. The reaction times were: detection immediately after adding the system, detection after 5 minutes, detection after 10 minutes, and detection after 15 minutes.

[0087] Experimental results: Figure 7 As shown, the reaction system has the best reaction effect after 5 minutes of reaction, so 5 minutes is selected as the reaction time to test the system.

[0088] Example 7

[0089] Effects of different solution concentrations and dosages on test results

[0090] 5 μL, 0.8 μg / mL lanthanide fluorescent microspheres labeled anti-ricin polyclonal antibody and 10 μL, 16 μg / mL allophycocyanin fluorescent dye labeled anti-ricin monoclonal antibody were selected, and 20 μL of 100 ng / mL and 1 ng / mL toxin concentrations were added for reaction; 7 μL, 0.8 μg / mL lanthanide fluorescent microspheres labeled anti-ricin polyclonal antibody and 7 μL, 16 μg / mL allophycocyanin fluorescent dye labeled anti-ricin monoclonal antibody were added for reaction at toxin concentrations of 7 μL 100 ng / mL and 1 ng / mL, and 30 μL, 0.8 μg / mL lanthanide fluorescent microspheres labeled anti-ricin polyclonal antibody and 60 μL, 16 μg / mL allophycocyanin fluorescent dye labeled anti-ricin monoclonal antibody were added for reaction at toxin concentrations of 120 μL 100 ng / mL and 1 ng / mL for comparison;

[0091] Experimental results: Figure 8 As shown in (a);

[0092] 5 μL, 0.8 μg / mL lanthanide fluorescent microsphere-labeled anti-ricin polyclonal antibody and 10 μL, 4 μg / mL, 16 μg / mL and 32 μg / mL allophycocyanin fluorescent dye-labeled anti-ricin monoclonal antibody were selected, and 20 μL of 100 ng / mL and 1 ng / mL toxin concentrations were added for reaction and comparison;

[0093] Experimental results: Figure 8 As shown in (b);

[0094] Select 5 μL, 0.2 μg / mL, 0.8 μg / mL, 2 μg / mL lanthanide fluorescent microspheres labeled anti-ricin polyclonal antibody and 10 μL, 16 μg / mL allophycocyanin fluorescent dye labeled anti-ricin monoclonal antibody, add 20 μL of 100 ng / mL and 1 ng / mL toxin concentrations for reaction, respectively.

[0095] Experimental results: Figure 8 As shown in (c) in .

[0096] In summary, whether the fluorescence intensity will change with the change of ricin toxin is closely related to the concentration of lanthanide fluorescent microspheres-coupled antibodies, the concentration of allophycocyanin dye-labeled antibodies and the total volume of the detection system solution. When the solution concentration and dosage are too small or exceed a certain range, the fluorescence value will not change significantly, and the lanthanide elements and allophycocyanin fluorescence will mask the detection signal, which will affect the detection results.

[0097] Example 8

[0098] After testing samples of different concentrations, the response curve of toxin concentration-fluorescence intensity change was drawn with the logarithm of ricin concentration as the horizontal axis and the fluorescence intensity as the vertical axis. After optimizing the relevant parameters, a standard curve of fluorescence intensity versus ricin concentration was drawn, which showed a good linear relationship in the concentration range of 1-100 ng / mL. The linear relationship was y=81874x+3×10 7 , linear correlation coefficient (R 2 ) is 0.9976. Figure 2 As shown. The minimum response value is calculated by adding the average measurement value of the blank solution to 3 times the standard deviation of the blank. After entering the equation, the detection limit (LOD) is 38 ng / mL. Fig. 9 shown.

[0099] It can be seen from the above examples that the present invention has established a homogeneous immunoassay method that can rapidly, specifically and sensitively detect ricin, and the detection limit can reach 38 ng / mL.

[0100] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A homogeneous immunoquantitative detection method for ricin, characterized in that: The following steps are involved: 1) mixing a lanthanide fluorescent microsphere suspension, NHS and EDC to obtain an activated lanthanide fluorescent microsphere suspension; mixing the activated lanthanide fluorescent microsphere suspension and an anti-ricin polyclonal antibody, and then adding a BSA solution to block the mixture to obtain a coupling solution A; 2) After the activated allophycocyanin and anti-ricin monoclonal antibody are reacted, DMSO solution is added for blocking to obtain coupling solution B; 3) at least three different concentrations of ricin standard solutions are mixed with coupling solution A and coupling solution B respectively to react, and after the reaction is completed, the time-resolved fluorescence of the system at 665 nm is measured, and a standard curve is established with the concentration of ricin as the abscissa and the fluorescence intensity at 665 nm corresponding to the concentration as the ordinate; After the coupling liquid A, coupling liquid B and ricin solution are mixed and reacted, the time-resolved fluorescence of the system at 665 nm is measured, and the content of ricin in the ricin solution is calculated based on the fluorescence intensity of the ricin solution and the standard curve.

2. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: Step 1) The particle size of the lanthanide fluorescent microspheres in the lanthanide fluorescent microsphere suspension is 80-120 nm; the coating amount of the lanthanide element in the lanthanide fluorescent microspheres is 0.2×10 -6 ~2×10 -6 mol / mL.

3. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: Step 3) The concentration of the coupling liquid A is 0.5-1 μg / mL; the concentration of the coupling liquid B is 10-20 μg / mL.

4. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: Step 3) The volume ratio of the coupling liquid A, coupling liquid B and ricin solution is 1:1-3:3-5.

5. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: The reaction time of step 3) is 5 to 15 minutes.

6. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: Step 1) The concentration of the lanthanide fluorescent microsphere suspension is 5-15%; the concentration of the NHS is 5-15 mg / mL; the concentration of the EDC is 5-15 mg / mL; the volume ratio of the lanthanide fluorescent microsphere suspension, NHS and EDC is 180-220:1:

1.

7. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: Step 1) The final concentration of the BSA solution is 0.3-0.8%; the mass ratio of the activated lanthanide fluorescent microsphere suspension, the anti-ricin polyclonal antibody and the BSA solution is 1:80-120:40-60.

8. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: In step 2), the mass ratio of the activated allophycocyanin to the anti-ricin monoclonal antibody is 1 to 3:

1.

9. The homogeneous immunoquantitative detection method of ricin according to claim 1, characterized in that: Step 2) The concentration of the DMSO solution is 5-15 mg / mL; the mass volume ratio of the anti-ricin monoclonal antibody and the DMSO solution is 0.3-0.8 mg:3-8 μL.

Citation Information

Patent Citations

  • Method for detecting recin

    CN101676727A

  • Rapid quantitative detection card for ricin

    CN112946256A

  • Homogeneous immunodetection method and kit for ricin

    CN114295843A

  • Ultra-sensitive time-resolved resonance energy transfer kit as well as preparation method and use method thereof

    CN118091120A

  • Method for quantitative detection of biological toxins

    US20070172904A1

Cited By

  • Method for determining extinction coefficient of toxin connexon in antibody-coupled drug and method for detecting drug-antibody coupling ratio in antibody-coupled drug

    CN120369658A